• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rack1 保护 N 端磷酸化的 c-Jun 免受 Fbw7 介导的降解。

Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation.

机构信息

Department of Cellular and Molecular Biology, The Hormel Institute, University of Minnesota, Austin, 55912, USA.

出版信息

Oncogene. 2012 Apr 5;31(14):1835-44. doi: 10.1038/onc.2011.369. Epub 2011 Aug 22.

DOI:10.1038/onc.2011.369
PMID:21860413
Abstract

The c-Jun transcription factor is a highly unstable oncoprotein. Several ubiquitin ligases mediate c-Jun degradation. However, c-Jun can be stabilized once it is phosphorylated at the N-terminus by c-Jun N-terminal kinases (JNKs) or other protein kinases. This phosphorylation decreases c-Jun ubiquitination and degradation. The underlying mechanism for this phenomenon is still unknown. Here, we show that receptor for activated C-kinase 1 (Rack1) can bind with c-Jun and ubiquitin ligase Fbw7 to form a complex. When c-Jun is phosphorylated at the N-terminus, c-Jun is released from the complex and cannot be ubiquitinated by Fbw7, which leads to increased stabilization and accumulation of c-Jun. These results reveal that Rack1 has a very important role in tumorigenesis by maintaining the stability of c-Jun that has been phosphorylated at its N-terminus by JNKs or other kinases.

摘要

c-Jun 转录因子是一种极不稳定的癌蛋白。几种泛素连接酶介导 c-Jun 的降解。然而,一旦 c-Jun 的 N 端被 c-Jun N 端激酶(JNK)或其他蛋白激酶磷酸化,它就可以稳定下来。这种磷酸化降低了 c-Jun 的泛素化和降解。这一现象的潜在机制尚不清楚。在这里,我们表明,激活的 C 激酶 1(Rack1)受体可以与 c-Jun 和泛素连接酶 Fbw7 结合形成复合物。当 c-Jun 的 N 端被磷酸化时,c-Jun 从复合物中释放出来,不能被 Fbw7 泛素化,这导致 c-Jun 的稳定性和积累增加。这些结果表明,Rack1 通过维持 JNK 或其他激酶磷酸化的 c-Jun 的稳定性,在肿瘤发生中起着非常重要的作用。

相似文献

1
Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation.Rack1 保护 N 端磷酸化的 c-Jun 免受 Fbw7 介导的降解。
Oncogene. 2012 Apr 5;31(14):1835-44. doi: 10.1038/onc.2011.369. Epub 2011 Aug 22.
2
The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling.泛素连接酶SCFFbw7拮抗凋亡性JNK信号传导。
Science. 2004 Feb 27;303(5662):1374-8. doi: 10.1126/science.1092880. Epub 2004 Jan 22.
3
Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).FBW7(含F盒/ WD重复序列蛋白7)和糖原合酶激酶3(GSK3)对NFE2L3(核因子,红细胞2样3;NRF3)蛋白降解的严格控制
J Biol Chem. 2015 Oct 23;290(43):26292-302. doi: 10.1074/jbc.M115.666446. Epub 2015 Aug 25.
4
Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.Fbw7通过泛素依赖性降解对GATA结合蛋白2水平的调控:细胞周期蛋白B-细胞周期蛋白依赖性激酶1介导的GATA结合蛋白2中苏氨酸176磷酸化的参与
J Biol Chem. 2015 Apr 17;290(16):10368-81. doi: 10.1074/jbc.M114.613018. Epub 2015 Feb 10.
5
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.SCF(FBW7)通过靶向 MCL1 进行泛素化和降解来调节细胞凋亡。
Nature. 2011 Mar 3;471(7336):104-9. doi: 10.1038/nature09732.
6
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.v-Jun点突变使c-Jun能够逃避Fbw7泛素连接酶介导的依赖GSK3的识别和破坏。
Cancer Cell. 2005 Jul;8(1):25-33. doi: 10.1016/j.ccr.2005.06.005.
7
Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.查菲埃立克体 TRP120 介导的肿瘤抑制因子 FBW7 的泛素化和蛋白酶体降解增加癌蛋白稳定性并促进感染。
PLoS Pathog. 2020 Apr 30;16(4):e1008541. doi: 10.1371/journal.ppat.1008541. eCollection 2020 Apr.
8
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.ERK激酶使胰腺癌中的肿瘤抑制因子FBW7磷酸化并使其不稳定。
Cell Res. 2015 May;25(5):561-73. doi: 10.1038/cr.2015.30. Epub 2015 Mar 10.
9
F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.F-box 和 WD 重复结构域蛋白 7 调节肠道细胞谱系决定,是一个杂合不足的肿瘤抑制因子。
Gastroenterology. 2010 Sep;139(3):929-41. doi: 10.1053/j.gastro.2010.05.078. Epub 2010 Jun 2.
10
Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV.c-Jun的E3泛素连接酶的转录抑制作用有助于紫外线诱导c-Jun的表达。
Cell Signal. 2008 May;20(5):862-71. doi: 10.1016/j.cellsig.2007.12.020. Epub 2008 Jan 5.

引用本文的文献

1
RACK1 is required for normal B cell development and signaling but not RAG1 degradation.正常B细胞发育和信号传导需要RACK1,但RAG1降解不需要。
J Immunol. 2025 Aug 24. doi: 10.1093/jimmun/vkaf217.
2
FBXW7 regulates MYRF levels to control myelin capacity and homeostasis in the adult central nervous system.FBXW7调节MYRF水平,以控制成年中枢神经系统中的髓鞘形成能力和内环境稳定。
Nat Commun. 2025 Aug 21;16(1):7822. doi: 10.1038/s41467-025-62715-9.
3
Rack1 promotes breast cancer stemness properties and tumorigenesis through the E2F1-SOX2 axis.
Rack1通过E2F1-SOX2轴促进乳腺癌干性特征和肿瘤发生。
Cancer Cell Int. 2025 Feb 12;25(1):40. doi: 10.1186/s12935-025-03678-1.
4
HIF-2α/LPCAT1 orchestrates the reprogramming of lipid metabolism in ccRCC by modulating the FBXW7-mediated ubiquitination of ACLY.缺氧诱导因子-2α/溶血磷脂酰胆碱酰基转移酶1通过调节FBXW7介导的ATP柠檬酸裂解酶泛素化来协调肾透明细胞癌中脂质代谢的重编程。
Int J Biol Sci. 2025 Jan 1;21(2):614-631. doi: 10.7150/ijbs.103032. eCollection 2025.
5
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.靶向细胞周期蛋白依赖性激酶2通过促使间变性甲状腺癌衰老而使乐伐替尼具有抗癌活性。
Adv Sci (Weinh). 2025 Feb;12(7):e2413514. doi: 10.1002/advs.202413514. Epub 2024 Dec 24.
6
Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.SCF E3 泛素连接酶的肿瘤抑制作用的分子见解和临床意义。
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189140. doi: 10.1016/j.bbcan.2024.189140. Epub 2024 Jun 21.
7
RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin.RACK1 通过竞争性抑制β-catenin 与 PSMD2 的结合并增强β-catenin 的稳定性促进乳腺癌的进展。
Cell Death Dis. 2023 Oct 17;14(10):685. doi: 10.1038/s41419-023-06191-3.
8
Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis.Fbw7通过靶向LDHA/乳酸/miR-223轴的正反馈环抑制活化B细胞样弥漫性大B细胞淋巴瘤的进展。
Front Oncol. 2022 Mar 10;12:842356. doi: 10.3389/fonc.2022.842356. eCollection 2022.
9
Clinical significance of FBXW7 loss of function in human cancers.FBXW7 功能丧失在人类癌症中的临床意义。
Mol Cancer. 2022 Mar 26;21(1):87. doi: 10.1186/s12943-022-01548-2.
10
Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.致癌性 Fbw7 突变的全球和特定情境转录后果。
Elife. 2022 Feb 28;11:e74338. doi: 10.7554/eLife.74338.